Skip to content
2000
Volume 26, Issue 30
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

The endothelium has a crucial role in proper hemodynamics. Inflammatory bowel disease (IBD) is mainly a chronic inflammatory condition of the gastrointestinal tract. However, considerable evidence points to high cardiovascular risk in patients with IBD. This review positions the basic mechanisms of endothelial dysfunction in the IBD setting (both clinical and experimental). Furthermore, we review the main effects of drugs used to treat IBD in endothelial (dys)function. Moreover, we leave challenging points for enlarging the therapeutic arsenal for IBD with new or repurposed drugs that target endothelial dysfunction besides inflammation.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/1381612826666200701212414
2020-08-01
2025-04-23
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/1381612826666200701212414
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test